The medical world is always looking for ways to help kids fight serious diseases. One such battle is against a condition called Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH). This is a mouthful, so let's break it down. EBV is a common virus that many people have. HLH is
The White House saw a significant event on a Monday afternoon. The president and the first lady stood together in the Rose Garden. Their mission? To bring a new law to life. This law is all about protecting people from a nasty problem: revenge porn. It is a form of online abuse that can ruin lives.
A major shift is happening in the world of genetic data. Regeneron, a big name in biotechnology, is stepping in to buy 23andMe, a company known for its DNA testing kits. The price tag? A cool $256 million. This move comes as 23andMe faces bankruptcy, but Regeneron has plans to keep the company runni
Men stand taller than women on average, by about five inches. This isn't universal across all species, though. So, what makes humans different? A recent study, which gathered genetic data from a million individuals, might have some answers. The study zeroed in on a gene called SHOX. This gene is li
Deepfakes, especially those of a sexual nature, have become a growing problem. These are images where someone's face is placed onto a nude body using artificial intelligence. This has affected many people, from celebrities like Taylor Swift to high school students across the country. After months of
One major player in the genetic testing world, 23andMe, has made a significant move. They sold their massive genetic data bank to a drug company, Regeneron Pharmaceuticals. The deal is worth 256 million dollars. This data bank holds genetic information from around 15 million people. The sale happene
A major change is happening in the world of genetic testing. Regeneron, a big name in pharmaceuticals, is set to buy 23andMe. The company is paying $256 million for this deal. This purchase happened after 23andMe went through a tough time and had to sell off its assets. 23andMe is known for its gen
The Federal Bureau of Investigation is currently looking into the real estate deals of the Democratic New York attorney general, Letitia James. This news was confirmed by FBI Director Kash Patel in a recent interview with Fox News. The focus of the investigation is on whether James was honest in her
The tech world is facing a significant challenge: a growing shortage of AI skills. This issue has become more pronounced, with almost double the number of tech leaders acknowledging a skills gap in their organizations compared to the previous year. This rapid increase highlights the urgent need for
Genetic testing has been a hot topic in health circles for years. However, not much thought has gone into how different communities view it. This is especially true for Latino groups. Researchers have looked at attitudes and clinical processes. Yet, they often miss out on using helpful theories. One
